442
Views
2
CrossRef citations to date
0
Altmetric
Comprehensive review

Association between health risk factors and dietary flavonoid intake in cohort studies

, &
Pages 1019-1034 | Received 25 Feb 2021, Accepted 23 Mar 2021, Published online: 07 Apr 2021

References

  • Banks E, Joshy G, Korda RJ, Stavreski B, Soga K, Egger S, Day C, Clarke NE, Lewington S, Lopez AD. 2019. Tobacco smoking and risk of 36 cardiovascular disease subtypes: fatal and non-fatal outcomes in a large prospective Australian study. BMC Med. 17(1):128.
  • Becker BJ, Wu MJ. 2007. The synthesis of regression slopes in meta-analysis. Statist Sci. 22(3):414–429.
  • Bondonno NP, Dalgaard F, Kyro C, Murray K, Bondonno CP, Lewis JR, Croft KD, Gislason G, Scalbert A, Cassidy A, et al. 2019. Flavonoid intake is associated with lower mortality in the Danish Diet Cancer and Health Cohort. Nat Commun. 10(1):3651.
  • Bowen KJ, Sullivan VK, Kris-Etherton PM, Petersen KS. 2018. Nutrition and cardiovascular disease-an update. Curr Atheroscler Rep. 20(2):8.
  • Bresciani L, Martini D, Mena P, Tassotti M, Calani L, Brigati G, Brighenti F, Holasek S, Malliga DE, Lamprecht M, et al. 2017. Absorption profile of (poly)phenolic compounds after consumption of three food supplements containing 36 different fruits, vegetables, and berries. Nutrients. 9(3):194.
  • Buttar HS, Li T, Ravi N. 2005. Prevention of cardiovascular diseases: role of exercise, dietary interventions, obesity and smoking cessation. Exp Clin Cardiol. 10(4):229–249.
  • Casas R, Castro-Barquero S, Estruch R, Sacanella E. 2018. Nutrition and cardiovascular health. Int J Mol Sci. 19:3988.
  • Cassidy A, Rimm EB, O'Reilly EJ, Logroscino G, Kay C, Chiuve SE, Rexrode KM. 2012. Dietary flavonoids and risk of stroke in women. Stroke. 43(4):946–951.
  • Chiva-Blanch G, Arranz S, Lamuela-Raventos RM, Estruch R. 2013. Effects of wine, alcohol and polyphenols on cardiovascular disease risk factors: evidences from human studies. Alcohol Alcohol. 48(3):270–277.
  • Ciumărnean L, Milaciu MV, Runcan O, Vesa ȘC, Răchișan AL, Negrean V, Perné M-G, Donca VI, Alexescu T-G, Para I, et al. 2020. The effects of flavonoids in cardiovascular diseases. Molecules. 25(18):4320.
  • Crichton GE, Elias MF, Davey A, Sauvageot N, Delagardelle C, Beissel J, Alkerwi A. 2014. Cardiovascular health: a cross-national comparison between the Maine Syracuse Study (Central New York, USA) and ORISCAV-LUX (Luxembourg). BMC Public Health. 14:253.
  • Crippa A, Orsini N. 2016. Dose-response meta-analysis of differences in means. BMC Med Res Methodol. 16:91.
  • Dalgaard F, Bondonno NP, Murray K, Bondonno CP, Lewis JR, Croft KD, Kyro C, Gislason G, Scalbert A, Cassidy A, et al. 2019. Associations between habitual flavonoid intake and hospital admissions for atherosclerotic cardiovascular disease: a prospective cohort study. Lancet Planet Health. 3(11):e450–e459.
  • Del Rio D, Costa LG, Lean ME, Crozier A. 2010. Polyphenols and health: what compounds are involved? Nutr Metab Cardiovasc Dis. 20(1):1–6.
  • Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, Crozier A. 2013. Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal. 18(14):1818–1892.
  • Desmarchelier C, Borel P. 2017. Overview of carotenoid bioavailability determinants: from dietary factors to host genetic variations. Trends Food Sci Technol. 69:270–280.
  • Egert S, Rimbach G. 2011. Which sources of flavonoids: complex diets or dietary supplements? Adv Nutr. 2(1):8–14.
  • Ganesan K, Xu B. 2017. Polyphenol-rich lentils and their health promoting effects. Int J Mol Sci. 18:2390.
  • GBD 2016 Alcohol Collaborators. 2018. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 392:1015–1035.
  • GBD 2017 Causes of Death Collaborators. 2018. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 392:1736–1788.
  • GBD 2017 Diet Collaborators. 2019. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 393:1958–1972.
  • GBD 2017 Risk Factor Collaborators. 2018. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 392:1923–1994.
  • Godos J, Marventano S, Mistretta A, Galvano F, Grosso G. 2017. Dietary sources of polyphenols in the Mediterranean healthy Eating, Aging and Lifestyle (MEAL) study cohort. Int J Food Sci Nutr. 68(6):750–756.
  • Godos J, Vitale M, Micek A, Ray S, Martini D, Del RD, Riccardi G, Galvano F, Grosso G. 2019. Dietary polyphenol intake, blood pressure, and hypertension: a systematic review and meta-analysis of observational studies. Antioxidants (Basel). 8:152.
  • Goetz ME, Judd SE, Safford MM, Hartman TJ, McClellan WM, Vaccarino V. 2016. Dietary flavonoid intake and incident coronary heart disease: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. Am J Clin Nutr. 104(5):1236–1244.
  • Goszcz K, Deakin SJ, Duthie GG, Stewart D, Leslie SJ, Megson IL. 2015. Antioxidants in cardiovascular therapy: panacea or false hope? Front Cardiovasc Med. 2:29.
  • Grosso G, Galvano F, Mistretta A, Marventano S, Nolfo F, Calabrese G, Buscemi S, Drago F, Veronesi U, Scuderi A. 2013. Red orange: experimental models and epidemiological evidence of its benefits on human health. Oxid Med Cell Longev. 2013:157240.
  • Grosso G, Godos J, Lamuela-Raventos R, Ray S, Micek A, Pajak A, Sciacca S, D’Orazio N, Del RD, Galvano F. 2017. A comprehensive meta-analysis on dietary flavonoid and lignan intake and cancer risk: level of evidence and limitations. Mol Nutr Food Res. 61(4).doi:https://doi.org/10.1002/mnfr.201600930
  • Grosso G, Micek A, Godos J, Pajak A, Sciacca S, Galvano F, Giovannucci EL. 2017. Dietary flavonoid and lignan intake and mortality in prospective cohort studies: systematic review and dose-response meta-analysis. Am J Epidemiol. 185(12):1304–1316.
  • Grosso G, Stepaniak U, Micek A, Stefler D, Bobak M, Pająk A. 2017. Dietary polyphenols are inversely associated with metabolic syndrome in Polish adults of the HAPIEE study. Eur J Nutr. 56(4):1409–1420.
  • Grosso G, Stepaniak U, Topor-Mądry R, Szafraniec K, Pająk A. 2014. Estimated dietary intake and major food sources of polyphenols in the Polish arm of the HAPIEE study. Nutrition. 30(11–12):1398–1403.
  • Guo XF, Ruan Y, Li ZH, Li D. 2019. Flavonoid subclasses and type 2 diabetes mellitus risk: a meta-analysis of prospective cohort studies. Crit Rev Food Sci Nutr. 59(17):2850–2862.
  • Hirvonen T, Pietinen P, Virtanen M, Ovaskainen ML, Hakkinen S, Albanes D, Virtamo J. 2001. Intake of flavonols and flavones and risk of coronary heart disease in male smokers. Epidemiology. 12(1):62–67.
  • Ivey KL, Hodgson JM, Croft KD, Lewis JR, Prince RL. 2015. Flavonoid intake and all-cause mortality. Am J Clin Nutr. 101(5):1012–1020.
  • Jin S, Liu J, Jia Y, Han T, Zhao X, Sun C, Na L. 2020. The association of dietary flavonoids, magnesium and their interaction effect with metabolic syndrome in Chinese adults: a prospective cohort study. Br J Nutr. 1–32 . doi:https://doi.org/10.1017/S0007114520004754
  • Kishimoto Y, Tani M, Kondo K. 2013. Pleiotropic preventive effects of dietary polyphenols in cardiovascular diseases. Eur J Clin Nutr. 67(5):532–535.
  • Knekt P, Jarvinen R, Reunanen A, Maatela J. 1996. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ. 312(7029):478–481.
  • Liberale L, Bonaventura A, Montecucco F, Dallegri F, Carbone F. 2019. Impact of red wine consumption on cardiovascular health. Curr Med Chem. 26(19):3542–3566.
  • Lin J, Rexrode KM, Hu F, Albert CM, Chae CU, Rimm EB, Stampfer MJ, Manson JE. 2007. Dietary intakes of flavonols and flavones and coronary heart disease in US women. Am J Epidemiol. 165(11):1305–1313.
  • Marino M, Del Bo C, Martini D, Porrini M, Riso P. 2020. A review of registered clinical trials on dietary (poly)phenols: past efforts and possible future directions. Foods. 9(11):1606.
  • Martinez-Gonzalez MA, Bes-Rastrollo M. 2014. Dietary patterns, Mediterranean diet, and cardiovascular disease. Curr Opin Lipidol. 25(1):20–26.
  • Martinez-Gonzalez MA, Peerez-Gutierrez R, Martinez-Gonzalez J, Garcia-Martin M, Bueno-Cavanillas A. 1997. Dietary intake of some food items in smokers and non-smokers in a Mediterranean population. Eur J Public Health. 7(1):40–44.
  • Martini D, Chiavaroli L, González-Sarrías A, Bresciani L, Palma-Duran SA, Dall’Asta M, Deligiannidou G-E, Massaro M, Scoditti E, Combet E, et al. 2019. Impact of foods and dietary supplements containing hydroxycinnamic acids on cardiometabolic biomarkers: a systematic review to explore inter-individual variability. Nutrients. 11(8):1805.
  • McClure JB, Divine G, Alexander G, Tolsma D, Rolnick SJ, Stopponi M, Richards J, Johnson CC. 2009. A comparison of smokers’ and nonsmokers’ fruit and vegetable intake and relevant psychosocial factors. Behav Med Spring. 35(1):14–22.
  • McCullough ML, Peterson JJ, Patel R, Jacques PF, Shah R, Dwyer JT. 2012. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr. 95(2):454–464.
  • Micek A, Godos J, Brzostek T, Gniadek A, Favari C, Mena P, Libra M, Del Rio D, Galvano F, Grosso G. 2021. Dietary phytoestrogens and biomarkers of their intake in relation to cancer survival and recurrence: a comprehensive systematic review with meta-analysis. Nutr Rev. 79(1):42–65.
  • Micek A, Godos J, Cernigliaro A, Cincione RI, Buscemi S, Libra M, Galvano F, Grosso G. 2021. Polyphenol-rich and alcoholic beverages and metabolic status in adults living in Sicily, Southern Italy. Foods. 10(2):383.
  • Micek A, Godos J, Rio DD, Galvano F, Grosso G. 2021. Dietary flavonoids and cardiovascular disease: a comprehensive dose-response meta-analysis. Mol Nutr Food Res. 65(6):e2001019.
  • Michalska M, Gluba A, Mikhailidis DP, Nowak P, Bielecka-Dabrowa A, Rysz J, Banach M. 2010. The role of polyphenols in cardiovascular disease. Med Sci Monit. 16(5):RA110–RA119.
  • Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA, Jacobs DR Jr. 2007. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr. 85(3):895–909.
  • Mishra R, Monica   2019. Determinants of cardiovascular disease and sequential decision-making for treatment among women: a Heckman’s approach. SSM Popul Health. 7:100365.
  • Muralidharan J, Galie S, Hernandez-Alonso P, Bullo M, Salas-Salvado J. 2019. Plant-based fat, dietary patterns rich in vegetable fat and gut microbiota modulation. Front Nutr. 6:157.
  • Mursu J, Voutilainen S, Nurmi T, Tuomainen TP, Kurl S, Salonen JT. 2008. Flavonoid intake and the risk of ischaemic stroke and CVD mortality in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr. 100(4):890–895.
  • Oga EA, Eseyin OR. 2016. The obesity paradox and heart failure: a systematic review of a decade of evidence. J Obes. 2016:9040248.
  • Ohkuma T, Komorita Y, Peters SAE, Woodward M. 2019. Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals. Diabetologia. 62(9):1550–1560.
  • Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. 2012. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 175(1):66–73.
  • Peterson JJ, Dwyer JT, Jacques PF, McCullough ML. 2012. Associations between flavonoids and cardiovascular disease incidence or mortality in European and US populations. Nutr Rev. 70(9):491–508.
  • Peterson JJ, Dwyer JT, Jacques PF, Mccullough ML. 2015. Improving the estimation of flavonoid intake for study of health outcomes. Nutr Rev. 73(8):553–576.
  • Petrie JR, Guzik TJ, Touyz RM. 2018. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 34(5):575–584.
  • Ponzo V, Goitre I, Fadda M, Gambino R, De Francesco A, Soldati L, Gentile L, Magistroni P, Cassader M, Bo S. 2015. Dietary flavonoid intake and cardiovascular risk: a population-based cohort study. J Transl Med. 13:218.
  • Raatz SK, Jahns L, Johnson LK, Scheett A, Carriquiry A, Lemieux A, Nakajima M, al’Absi M. 2017. Smokers report lower intake of key nutrients than nonsmokers, yet both fall short of meeting recommended intakes. Nutr Res. 45:30–37.
  • Reboul E, Thap S, Perrot E, Amiot MJ, Lairon D, Borel P. 2007. Effect of the main dietary antioxidants (carotenoids, gamma-tocopherol, polyphenols, and vitamin C) on alpha-tocopherol absorption. Eur J Clin Nutr. 61(10):1167–1173.
  • Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett WC. 1996. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med. 125(5):384–389.
  • Sánchez-Villegas A, Sánchez-Tainta A. 2018. The prevention of cardiovascular disease through the Mediterranean Diet. London; San Diego (CA): Academic Press.
  • Sebastian RS, Wilkinson Enns C, Goldman JD, Moshfegh AJ. 2017. Dietary flavonoid intake is inversely associated with cardiovascular disease risk as assessed by body mass index and waist circumference among adults in the United States. Nutrients. 9:827.
  • Sesso HD, Gaziano JM, Liu S, Buring JE. 2003. Flavonoid intake and the risk of cardiovascular disease in women. Am J Clin Nutr. 77(6):1400–1408.
  • Shakeela Begum M, Saradamma B, Reddy VD, Padmavathi P, Maturu P, Ellutla N, Thippannagari L, Varadacharyulu NC. 2017. Influence of green tea consumption on cigarette smoking-induced biochemical changes in plasma and blood. Clin Nutr Exp. 16:1–12.
  • Speer H, D’Cunha NM, Botek M, McKune AJ, Sergi D, Georgousopoulou E, Mellor DD, Naumovski N. 2019. The effects of dietary polyphenols on circulating cardiovascular disease biomarkers and iron status: a systematic review. Nutr Metab Insights. 12:1178638819882739.
  • Stukel TA, Demidenko E. 1997. Two-stage method of estimation for general linear growth curve models. Biometrics. 53(2):720–728.
  • Tangney CC, Rasmussen HE. 2013. Polyphenols, inflammation, and cardiovascular disease. Curr Atheroscler Rep. 15(5):324.
  • Tappia PS, Blewett H. 2020. Nutrition and cardiovascular health. Int J Mol Sci. 21:2284.
  • Threapleton DE, Greenwood DC, Evans CE, Cleghorn CL, Nykjaer C, Woodhead C, Cade JE, Gale CP, Burley VJ. 2013. Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis. BMJ. 347:f6879.
  • Wang H, Ba Y, Cai RC, Xing Q. 2019. Association between diabetes mellitus and the risk for major cardiovascular outcomes and all-cause mortality in women compared with men: a meta-analysis of prospective cohort studies. BMJ Open. 9(7):e024935.
  • Wang Y, Chun OK, Song WO. 2013. Plasma and dietary antioxidant status as cardiovascular disease risk factors: a review of human studies. Nutrients. 5(8):2969–3004.
  • Wang ZM, Zhou B, Nie ZL, Gao W, Wang YS, Zhao H, Zhu J, Yan JJ, Yang ZJ, Wang LS. 2012. Folate and risk of coronary heart disease: a meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis. 22(10):890–899.
  • Wells GA, Shea B, O’Connell D, Peterson JJ, Welch V, Losos M, Tugwell P. 2014. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [accessed 2019 July 19]. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
  • Xu H, Luo J, Huang J, Wen Q. 2018. Flavonoids intake and risk of type 2 diabetes mellitus: a meta-analysis of prospective cohort studies. Medicine (Baltimore). 97(19):e0686.
  • Yeh TL, Chen HH, Tsai SY, Lin CY, Liu SJ, Chien KL. 2019. The relationship between metabolically healthy obesity and the risk of cardiovascular disease: a systematic review and meta-analysis. J Clin Med. 8:1228.
  • Yochum L, Kushi LH, Meyer K, Folsom AR. 1999. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol. 149(10):943–949.
  • Zamora-Ros R, Knaze V, Rothwell JA, Hémon B, Moskal A, Overvad K, Tjønneland A, Kyrø C, Fagherazzi G, Boutron-Ruault M-C, et al. 2016. Dietary polyphenol intake in Europe: the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur J Nutr. 55(4):1359–1375.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.